PAA 2.86% 18.0¢ pharmaust limited

Clinical Trials, page-253

  1. 192 Posts.
    lightbulb Created with Sketch. 92
    Not usually one to upramp much, but come on, PAA has 1: a possible (likely even) upcoming deal with Vet major on successful phase 2 canine trial for cancer, the proceeds of which could fund 2: phase 2 human trials (for potentially multiple cancers!!!) and in the meantime, 3: the likelihood of human trials for Covid 19 with 95% effectiveness against virus, and who knows what other viruses in future through the cutting edge mTor inhibitor. Make it in one of these and we're off- imagine a commercial deal in all 3- bang bang bang. And don't forget Epichem, which is quietly expanding and seeking out new contracts. Does it get better than this? not in my VERY limited experience. I still shake my head at the potential calculations here- as if im missing something. Early days, dyor
    Last edited by ArtistPete: 03/07/20
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
18.0¢
Change
0.005(2.86%)
Mkt cap ! $71.26M
Open High Low Value Volume
17.5¢ 18.0¢ 17.5¢ $134.5K 752.7K

Buyers (Bids)

No. Vol. Price($)
9 91508 17.5¢
 

Sellers (Offers)

Price($) Vol. No.
18.0¢ 445257 8
View Market Depth
Last trade - 15.00pm 22/05/2024 (20 minute delay) ?
Last
18.0¢
  Change
0.005 ( 0.00 %)
Open High Low Volume
18.0¢ 18.0¢ 17.5¢ 117244
Last updated 12.50pm 22/05/2024 ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.